Patents by Inventor Lionel Resnick

Lionel Resnick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160361249
    Abstract: Compositions and methods of treatment are disclosed using compositions of extracts from the fruit of the Synsepalum dulcificum tree, which when applied topically in mammals, can provide benefit for dermatological and joint conditions. The extracts also contain anti-inflammatory, antimicrobial and spermicidal activity in vitro.
    Type: Application
    Filed: August 5, 2016
    Publication date: December 15, 2016
    Inventors: Elizabeth Resnick, Lionel Resnick, Adam Resnick
  • Patent number: 8765808
    Abstract: The NSAID, sulindac and/or its metabolites and derivatives, in combination with hydrogen peroxide or another oxidizing agent, such as arsenic trioxide that generates reactive oxygen species (ROS), significantly enhances the killing of cancer cells. This effect occurs at concentrations of each compound that individually have little or no activity directed against cancer cells. A skin cream has been developed and used to treat skin cancer and precancerous skin growths that effectively removes the lesions with no effect on surrounding normal skin.
    Type: Grant
    Filed: October 26, 2007
    Date of Patent: July 1, 2014
    Assignee: CHS Pharma, Inc.
    Inventors: Herbert Weissbach, Lionel Resnick, David Binninger
  • Publication number: 20140079657
    Abstract: Compositions and methods of treatment are disclosed using compositions of extracts from the fruit of the Synsepalum dulcificum tree, which when applied topically in mammals, can provide benefit for dermatological and joint conditions. The extracts also contain anti-inflammatory, antimicrobial and spermicidal activity in vitro.
    Type: Application
    Filed: September 12, 2013
    Publication date: March 20, 2014
    Inventors: Elizabeth Resnick, Lionel Resnick, Adam Resnick
  • Patent number: 8603985
    Abstract: The NSAID, sulindac and/or its metabolites and derivatives, in combination with hydrogen peroxide or another oxidizing agent, such as arsenic trioxide that generates reactive oxygen species (ROS), significantly enhances the killing of cancer cells. This effect occurs at concentrations of each compound that individually have little or no activity directed against cancer cells. A skin cream has been developed and used to treat skin cancer and precancerous skin growths that effectively removes the lesions with no effect on surrounding normal skin.
    Type: Grant
    Filed: April 14, 2010
    Date of Patent: December 10, 2013
    Assignee: CHS Pharma, Inc
    Inventors: Herbert Weissbach, Lionel Resnick, David Binninger
  • Patent number: 8414872
    Abstract: The present invention includes a hair straightening formulation consisting of a hair fixative that will straighten the hair for at least 2-3 months after one application despite frequent washings of the hair as well as methods for obtaining said formulation. The formulation comprises as active ingredients one or more keratin hydrolysates and an aldehyde. Hair straightening system comprising shampoo and one or more conditioners are also provided. The invention is further directed to a method for straightening hair using said formulation.
    Type: Grant
    Filed: September 8, 2008
    Date of Patent: April 9, 2013
    Assignee: Liquid Keratin, Inc.
    Inventors: Lionel Resnick, Irwin Grams, Angela Goodfellow, David Allice
  • Patent number: 8357720
    Abstract: The NSAID, sulindac and/or its metabolites and derivatives, in combination with an agent that generates or induces reactive oxygen species (ROS), significantly enhances the killing of abnormal cells but does not affect normal cells. This effect occurs at concentrations of each compound that individually have little or no activity directed against the abnormal cells.
    Type: Grant
    Filed: September 10, 2009
    Date of Patent: January 22, 2013
    Assignee: Florida Atlantic University
    Inventors: Herbert Weissbach, Lionel Resnick, David Binninger
  • Patent number: 8258181
    Abstract: The NSAID, sulindac and/or its metabolites and derivatives, in combination with hydrogen peroxide or another oxidizing agent, such as arsenic trioxide that generates reactive oxygen species (ROS), significantly enhances the killing of cancer cells. This effect occurs at concentrations of each compound that individually have little or no activity directed against cancer cells. A skin cream has been developed and used to treat skin cancer and precancerous skin growths that effectively removes the lesions with no effect on surrounding normal skin.
    Type: Grant
    Filed: March 23, 2006
    Date of Patent: September 4, 2012
    Assignee: Florida Atlantic University
    Inventors: Herbert Weissbach, Lionel Resnick, David Binninger
  • Publication number: 20100260864
    Abstract: The NSAID, sulindac and/or its metabolites and derivatives, in combination with hydrogen peroxide or another oxidizing agent, such as arsenic trioxide that generates reactive oxygen species (ROS), significantly enhances the killing of cancer cells. This effect occurs at concentrations of each compound that individually have little or no activity directed against cancer cells. A skin cream has been developed and used to treat skin cancer and precancerous skin growths that effectively removes the lesions with no effect on surrounding normal skin.
    Type: Application
    Filed: April 14, 2010
    Publication date: October 14, 2010
    Applicant: Florida Atlantic University
    Inventors: Herbert Weissbach, Lionel Resnick, David Binninger
  • Publication number: 20100069331
    Abstract: The NSAID, sulindac and/or its metabolites and derivatives, in combination with an agent that generates or induces reactive oxygen species (ROS), significantly enhances the killing of abnormal cells but does not affect normal cells. This effect occurs at concentrations of each compound that individually have little or no activity directed against the abnormal cells.
    Type: Application
    Filed: September 10, 2009
    Publication date: March 18, 2010
    Applicant: Florida Atlantic University
    Inventors: Herbert Weissbach, Lionel Resnick, David Binninger
  • Publication number: 20090165812
    Abstract: The present invention includes a hair straightening formulation consisting of a hair fixative that will straighten the hair for at least 2-3 months after one application despite frequent washings of the hair as well as methods for obtaining said formulation. The formulation comprises as active ingredients one or more keratin hydrolysates and an aldehyde. Hair straightening system comprising shampoo and one or more conditioners are also provided. The invention is further directed to a method for straightening hair using said formulation.
    Type: Application
    Filed: September 8, 2008
    Publication date: July 2, 2009
    Inventors: Lionel Resnick, Irwin Grams, Angela Goodfellow, David Allice
  • Publication number: 20080119559
    Abstract: The NSAID, sulindac and/or its metabolites and derivatives, in combination with hydrogen peroxide or another oxidizing agent, such as arsenic trioxide that generates reactive oxygen species (ROS), significantly enhances the killing of cancer cells. This effect occurs at concentrations of each compound that individually have little or no activity directed against cancer cells. A skin cream has been developed and used to treat skin cancer and precancerous skin growths that effectively removes the lesions with no effect on surrounding normal skin.
    Type: Application
    Filed: October 26, 2007
    Publication date: May 22, 2008
    Applicant: Florida Atlantic University
    Inventors: HERBERT WEISSBACH, Lionel Resnick, David Binninger
  • Publication number: 20060235080
    Abstract: The NSAID, sulindac and/or its metabolites and derivatives, in combination with hydrogen peroxide or another oxidizing agent, such as arsenic trioxide that generates reactive oxygen species (ROS), significantly enhances the killing of cancer cells. This effect occurs at concentrations of each compound that individually have little or no activity directed against cancer cells. A skin cream has been developed and used to treat skin cancer and precancerous skin growths that effectively removes the lesions with no effect on surrounding normal skin.
    Type: Application
    Filed: March 23, 2006
    Publication date: October 19, 2006
    Applicant: Florida Atlantic University
    Inventors: Herbert Weissbach, Lionel Resnick, David Binninger